A Day of Updates on the Progress of ALS Research

Friday, October 27, 2023

Boston Sheraton Hotel

39 Dalton St, Boston, MA 02199

On Friday, October 27, 2023, from 10:00 - 4:00 p.m. ET, join the ALS community and ALS TDI for the ALS TDI Summit. The ALS TDI Summit is a free conference that aims to inform and empower the ALS community by educating attendees about ALS TDI's latest work to discover and develop effective treatments for ALS. The Summit invites all members of the community to learn about ALS TDI's cutting-edge approach to ending ALS.

This year along with the full in-person Summit, the ALS TDI Summit will be filmed live and streamed over YouTube. Register to attend the 2023 ALS TDI Summit virtually or in person!

The ALS TDI Summit is a free annual conference hosted by ALS TDI, the Drug Discovery Engine for ALS. The event aims to inform community members and scientists by providing updates on current ALS research. 

The Summit includes:

• ● Presentations on ALS TDI’s current research led by members of our science team
• ● Guest presentations from leading experts in ALS research
• ● Presentation of the ALS TDI Leadership Awards to members of the community
• 
  

2023 ALS TDI Summit: List of Presenters 

ALS TDI Presenters: 

• Fernando Vieira M.D. CEO and Chief Scientific Officer 

• Theo Hatzipetros, Ph.D. Director of Pharmacology 

• Kyle Denton, Ph.D. Director, Cell Biology 

• Alan Premasiri, Senior Manager, Clinical Operations

• Nadia Sethi, D.D.S. Director of Community Engagement and Outreach 

Guest Presenters: 

• James Larrick, M.D, Ph.D. Co-founder and Managing Partner, Corsalex 

• Stephanie M. Fradette, Pharm.D. Senior Medical Director, Clinical Development, Biogen  

• James Berry, M.D, M.P.H. Associate Chief of Neuro-therapeutics and Chief of the Division of ALS and Motor Neuron Diseases,
  

• MGH 

2023 ALS TDI Summit Agenda

• 9:00 am – Registration Opens 
• 10:00 am – Welcome address and ALS TDI Presentations
• Collaborative Science in Service of Ending ALS | Fernando Vieira, M.D. CEO & Chief Scientific Officer 
• ALS Research Collaborative: Tackling ALS Together | Alan Premasiri, M.S. Manager, Clinical Operations 
• Collaborative Approaches for Studying and Treating ALS via the Use of Animal Models | Theo Hatzipetros, Ph.D. Director of Pharmacology
• iPS Cell Biology Models and Techniques for ALS Discovery | Kyle Denton, Ph.D. Director, Cell Biology 
• Unveiling an Innovative Tool for Tailored Clinical Trial Recommendations | Nadia Sethi, D.D.S. Director of Community Outreach and Engagement 
• 11:50 am – ALS TDI Scientist Panel Discussion 
• 12:20 pm – Lunch & Networking 
• 1:30 pm – Guest Presentations
• A Veteran Physician-Scientist Reflects on Advances in ALS: From Early Biotech to the Present | James Larrick, M.D, Ph.D. Co-founder and Managing Partner, Corsalex
• The Development of Tofersen for SOD1-ALS | Stephanie M. Fradette, Pharm.D. Senior Medical Director, Clinical Development, Biogen
• Title TBD | James Berry, M.D, M.P.H, Associate Chief of Neuro-therapeutics and Chief of the Division of ALS and Motor Neuron Diseases, MGH
• 3:00 pm – Short Break 
• 3:15 pm – Leadership Awards Presentations
• 4:00 pm – Conversations and Cocktails: an ALS TDI Poster Session

Who Should Attend the ALS TDI Summit?

The ALS TDI Summit is free and is open to all members of the ALS community, including:

- people with ALS

- caregivers

- friends and family members

- members of the ALS research and science community

We hope you can join us at the Summit to learn more about the progress we are making together.

All of our progress to end ALS is thanks to the support of the ALS community.

Thank you to our sponsors of the ALS TDI Leadership Weekend